Prophylactic use of TMP-SMZ in leukemia.
D000380:Agranulocytosis / Q000139:chemically induced*; D002648:Child; D004338:Drug Combinations / Q000009:adverse effects; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced*; D011658:Pulmonary Fibrosis / Q000517:prevention & control*; D013420:Sulfamethoxazole / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000139:chemically induced*; D014295:Trimethoprim / Q000009:adverse effects*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination
D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole